357 related articles for article (PubMed ID: 16869111)
21. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
22. Advances in the early detection of Alzheimer's disease.
Nestor PJ; Scheltens P; Hodges JR
Nat Med; 2004 Jul; 10 Suppl():S34-41. PubMed ID: 15298007
[TBL] [Abstract][Full Text] [Related]
23. Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
Small BJ; Gagnon E; Robinson B
Geriatrics; 2007 Apr; 62(4):19-23. PubMed ID: 17408315
[TBL] [Abstract][Full Text] [Related]
24. Preclinical Alzheimer's disease: diagnosis and prediction of progression.
Chong MS; Sahadevan S
Lancet Neurol; 2005 Sep; 4(9):576-9. PubMed ID: 16109364
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers of Alzheimer's disease in body fluids.
Zheng Y; He J; Hong T
Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
[TBL] [Abstract][Full Text] [Related]
26. Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment.
Bermejo P; Martín-Aragón S; Benedí J; Susín C; Felici E; Gil P; Ribera JM; Villar AM
Free Radic Res; 2008 Feb; 42(2):162-70. PubMed ID: 18297609
[TBL] [Abstract][Full Text] [Related]
27. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
[TBL] [Abstract][Full Text] [Related]
28. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
Lee JW; Namkoong H; Kim HK; Kim S; Hwang DW; Na HR; Ha SA; Kim JR; Kim JW
BMC Neurol; 2007 Jun; 7():14. PubMed ID: 17565664
[TBL] [Abstract][Full Text] [Related]
29. Conceptualization of mild cognitive impairment: a review.
Davis HS; Rockwood K
Int J Geriatr Psychiatry; 2004 Apr; 19(4):313-9. PubMed ID: 15065223
[TBL] [Abstract][Full Text] [Related]
30. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
[TBL] [Abstract][Full Text] [Related]
32. Neurochemical dementia diagnostics: State of the art and research perspectives.
Lewczuk P; Wiltfang J
Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
[TBL] [Abstract][Full Text] [Related]
33. Imaging and biomarkers for Alzheimer's disease.
Allan CL; Sexton CE; Welchew D; Ebmeier KP
Maturitas; 2010 Feb; 65(2):138-42. PubMed ID: 20060241
[TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment. When is it a precursor to Alzheimer's disease?
Shah Y; Tangalos EG; Petersen RC
Geriatrics; 2000 Sep; 55(9):62, 65-8. PubMed ID: 10997127
[TBL] [Abstract][Full Text] [Related]
35. Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.
Galimberti D; Fenoglio C; Lovati C; Venturelli E; Guidi I; Corrà B; Scalabrini D; Clerici F; Mariani C; Bresolin N; Scarpini E
Neurobiol Aging; 2006 Dec; 27(12):1763-8. PubMed ID: 16307829
[TBL] [Abstract][Full Text] [Related]
36. Episodic memory and speed/attention deficits are associated with Alzheimer-typical CSF abnormalities in MCI.
Nordlund A; Rolstad S; Klang O; Lind K; Pedersen M; Blennow K; Edman A; Hansen S; Wallin A
J Int Neuropsychol Soc; 2008 Jul; 14(4):582-90. PubMed ID: 18577287
[TBL] [Abstract][Full Text] [Related]
37. CSF tau/Abeta42 ratio for increased risk of mild cognitive impairment: a follow-up study.
Li G; Sokal I; Quinn JF; Leverenz JB; Brodey M; Schellenberg GD; Kaye JA; Raskind MA; Zhang J; Peskind ER; Montine TJ
Neurology; 2007 Aug; 69(7):631-9. PubMed ID: 17698783
[TBL] [Abstract][Full Text] [Related]
38. [Mild cognitive impairment: A review of the literature].
Hödl AK; Bonelli RM; Kapfhammer HP
MMW Fortschr Med; 2005 Jun; 147(23):40-3. PubMed ID: 15981904
[TBL] [Abstract][Full Text] [Related]
39. CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.
Blennow K
Expert Rev Mol Diagn; 2005 Sep; 5(5):661-72. PubMed ID: 16149870
[TBL] [Abstract][Full Text] [Related]
40. [Predementia syndromes and mild cognitive impairment: diagnosis and progression to dementia].
Panza F; D'Introno A; Colacicco AM; Capurso C; Gagliardi G; Capurso A; Solfrizzi V
Recenti Prog Med; 2007 May; 98(5):281-9. PubMed ID: 17580519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
